INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$213K

$213,177

View Combined Trades

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin Joseph • Officer • CSO & EVP, Head of Research 10b5-1 Sell 2026-03-05 $75,317 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Fitzgerald Kevin Joseph Officer • CSO & EVP, Head of Research 10b5-1 Sell	2026-03-05	$75,317	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin Joseph • Officer • CSO & EVP, Head of Research 10b5-1 Sell 2026-03-05 $49,915 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Fitzgerald Kevin Joseph Officer • CSO & EVP, Head of Research 10b5-1 Sell	2026-03-05	$49,915	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin Joseph • Officer • CSO & EVP, Head of Research 10b5-1 Sell 2026-03-05 $48,041 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Fitzgerald Kevin Joseph Officer • CSO & EVP, Head of Research 10b5-1 Sell	2026-03-05	$48,041	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin Joseph • Officer • CSO & EVP, Head of Research 10b5-1 Sell 2026-03-05 $39,904 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Fitzgerald Kevin Joseph Officer • CSO & EVP, Head of Research 10b5-1 Sell	2026-03-05	$39,904	S	Form 4